abstract |
The instant invention relates to a synergistic combination of an alpha-2-delta ligand and an NMDA, suitably NR2B, receptor antagonist, or pharmaceutically acceptable salts, esters or solvates thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly neuropathic pain, and disorders of the central nervous system. |